1.Abdominal pain in a lupus patient.
Korean Journal of Medicine 2000;58(2):244-244
No abstract available.
Abdominal Pain*
;
Humans
2.Evaluation of disease activity in rheumatoid arthritis.
Korean Journal of Medicine 1999;57(5):965-966
No abstract available.
Arthritis, Rheumatoid*
3.Evaluation of disease activity in rheumatoid arthritis.
Korean Journal of Medicine 1999;57(5):965-966
No abstract available.
Arthritis, Rheumatoid*
4.A case of organic hallucinous following phendimetrazine(Fringar@) abuse.
Sung Ho KIM ; Dong Hyun AHN ; Tae Hyuk YOO
Journal of Korean Neuropsychiatric Association 1992;31(6):1119-1122
No abstract available.
5.A case of organic hallucinous following phendimetrazine(Fringar@) abuse.
Sung Ho KIM ; Dong Hyun AHN ; Tae Hyuk YOO
Journal of Korean Neuropsychiatric Association 1992;31(6):1119-1122
No abstract available.
6.Operative versus non-operative treatment of the isolated medialcollateral ligament injury of the knee.
Young Bok JUNG ; Seok Ki TAE ; Hyun Wook YOO
Journal of the Korean Knee Society 1992;4(2):216-220
No abstract available.
Knee*
;
Ligaments*
7.The Dual Muscle Flap Based on the Thoraco-Dorsal Vascular System for Limb Reconstruction.
Young Tae SEO ; Jin Whan CHO ; Yoo Hyun BANG
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1999;26(5):957-960
The dual muscle flap (Latissimus dorsi+ Serratus anterior muscle) based on the thoraco-dorsal vascular system for limb reconstruction has been infrequently reported. We have used this flap as a free flap for limb reconstruction in four patients (3 cases in lower linb, 1 in upper limb). A Latissmusi dorsi muscle or musculocutaneous flap and Serratus anterior muscle flap were used and all cases healed satisfactorily. The indications for this flap are to resurface two separate defects simultaneously or to resurface very large defects. It has the advantage of requiring anastomosis of one vascular pedicle only. This flap is particularly suitable for resurfacing defects wider than their length, in relation to the long axis of the limb.
Axis, Cervical Vertebra
;
Extremities*
;
Free Tissue Flaps
;
Humans
;
Myocutaneous Flap
8.Growth hormone response to peripheral infusion of clonidine in patients with panic disorder, major depression and alcohol dependence(1 ).
Joo Jin KIM ; Dong Hyun AHN ; Tae Hyuk YOO
Journal of Korean Neuropsychiatric Association 1992;31(3):488-498
No abstract available.
Clonidine*
;
Depression*
;
Growth Hormone*
;
Humans
;
Panic Disorder*
;
Panic*
9.A Clinical Study of Panoxyl 2.5(R) in Acne Vulgaris.
Kwang Hyun CHO ; Tae Joong NAM ; Won Suk KIM ; Hong Sik KIM ; Yoo Shin LEE
Korean Journal of Dermatology 1979;17(3):155-170
Bezoyl peroxide, a powerful oxidizing agent, has been uaed topically in the treatment of acne vulgaris as a cream or lotion and has been shown to he effective for this codition. In 1972 Fulton emphaaized the importance of the vehicles used to obtain. maximum potential of benzoyl peroxide and for this, the gel formulation has been examined in many clinical trials. The present study was undertaken to evaluate the therapeutic effect of Fanoxyl 2.5, a 2.5% . benzayl peraxide gel, in patients with acne vulgaris. A total of 31 patients entered this study at the Departrnent of Dermatology, Jeoul National University Hospital rluring 3 rnanths period, from Decemher, 1978 through February, 1979, All patienta were instructed to apply Fanoxyl 2.5' on their affected areas once or twice a day and the nurnber of lesions on two or three t fixed areas were counted before and onee weekly after initation of the treatment. The reaults observed in the 3I patients were as follaws; 1. The percentage decrease in total nurnber of lesions in 4 weeks after treatment was 56.9%. 2. The authors could follow up for 6 weeks in 6 cases. In 6 case, the mean percentage in total number of lesions in 6 weeks after treatment was 81.7%. 3. Clesed and open eomedones were gradually eliminated; and their numbers were decreased in 4 weeks after treatment by 46.5% and 56.8% respeetiveIy. The papules were rapidly eliminated and their numbers were decreased in 4 weeka, after treatment by 79.8%. 4. Although most patients felt a mild burning sensation and tightness at the begining of the treatment, only a minority of the patients complained of discomfort due to pain(l case), erytherna(l case), tightness(2 cases),burning sensation (1 case), scaling(1 case). But all were tolerable without taking any specific measures or discontinuance of application. In one case, contact dermatitis developed after 4 weeks treatment. The authors concluded through this experiment that Panoxyl 2.5' (2.5% benzoyl peroxide gel) is a very effective local therapeutic agent in the treatment of acne vulgaris patients.
Acne Vulgaris*
;
Benzoyl Peroxide*
;
Burns
;
Dermatitis, Contact
;
Dermatology
;
Follow-Up Studies
;
Humans
;
Sensation
10.Nonimmunologic targets of immunosuppressive agents in podocytes.
Tae Hyun YOO ; Alessia FORNONI
Kidney Research and Clinical Practice 2015;34(2):69-75
Proteinuria is a characteristic finding in glomerular diseases and is closely associated with renal outcomes. In addition, therapeutic interventions that reduce proteinuria improve renal prognosis. Accumulating evidence has demonstrated that podocytes act as key modulators of glomerular injury and proteinuria. The podocyte, or glomerular visceral epithelial cell, is a highly specialized and differentiated cell that forms interdigitated foot processes with neighboring podocytes, which are bridged together by an extracellular structure known as the "slit diaphragm" (SD). The SD acts as a size- and charge-selective barrier to plasma protein. Derangement of SD structure or loss of SD-associated protein results in podocyte injury and proteinuria. During the past decades, several immune-modulating agents have been used for the treatment of glomerular diseases and for the reduction of proteinuria. Interestingly, recent studies have demonstrated that immunosuppressive agents can have a direct effect on the SD-associated proteins and stabilize actin cytoskeleton in podocyte and have therefore introduced the concept of nonimmunologic mechanism of renoprotection by immunomodulators. This review focuses on the evidence that immuno-modulating agents directly target podocytes.
Actin Cytoskeleton
;
Epithelial Cells
;
Foot
;
Immunologic Factors
;
Immunomodulation
;
Immunosuppressive Agents*
;
Nephrotic Syndrome
;
Plasma
;
Podocytes*
;
Prognosis
;
Proteinuria